Diagnosis and management of dementia with Lewy bodies

The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in widespread use for the last decade. The revised DLB consensus criteria now distinguish clearly between clinical features and diagnostic biomarkers, and give guidance about optimal methods to establish and interpret these. Substantial new information has been incorporated about previously reported aspects of DLB, with increased diagnostic weighting given to REM sleep behavior disorder and 123 iodine-metaiodobenzylguanidine (MIBG) myocardial scintigraphy. The diagnostic role of other neuroimaging, electrophysiologic, and laboratory…

• UD
  U.S. Department of Health and Human Services
• UD
  U.S. Department of Veterans Affairs
• CI
  California Institute for Regenerative Medicine
• BS
  Bristol-Myers Squibb
• AD
  Alzheimer's Drug Discovery Foundation
• EL
  Eli Lilly and Company
• P
  Pfizer
• S
  Sanofi
• HA
  Heart and Stroke Foundation of Canada
• MG
  Massachusetts General Hospital
• VA
  Van Andel Research Institute
• B
  Biogen
• CF
  CHDI Foundation
• TP
  Teva Pharmaceutical Industries
• FD
  Florida Department of Health
• UO
  University of Pennsylvania
• CC
  Cleveland Clinic
• UO
  University of Washington
• IP
  International Parkinson and Movement Disorder Society
• TJ
  Thomas Jefferson University
• C
  CurePSP
• RU
  Rush University
• FA
  Florida Atlantic University
• FB
  Fondation Brain Canada
• LF
  Little Family Foundation
• D
  Demensförbundet
• WB
  Weston Brain Institute
• AP
  ACADIA Pharmaceuticals
• HM
  Houston Methodist Hospital
• UD
  Universidad del Atlántico
• KU
  Kanazawa University
• TP
  TauRx Pharmaceuticals
• NI
  National Institute for Health and Care Research
• UO
  University of Exeter
• KC
  King's College London
• UC
  University College London
• UO
  University of Oxford
• NU
  Newcastle University
• MD
  Ministero della Salute
• UO
  University of Toronto
• UD
  Université de Strasbourg
• E
  Eisai
• NU
  Newcastle upon Tyne Hospitals NHS Foundation Trust
• CN
  Centre National de la Recherche Scientifique
• MD
  Ministero dello Sviluppo Economico
• HL
  H. Lundbeck A/S
• NI
  National Institutes of Health
• G
  Genentech
• UO
  University of North Carolina at Chapel Hill
• UO
  University of California, San Diego
• PS
  Perelman School of Medicine, University of Pennsylvania
• AR
  Avid Radiopharmaceuticals
• HM
  Houston Methodist Research Institute
• QB
  Qatar Biomedical Research Institute, Hamad Bin Khalifa University
• CI
  Canadian Institutes of Health Research
• MR
  Medical Research Council

  Award: MR/L016451/1
• NH
  National Health and Medical Research Council
• PG
  Programme Grants for Applied Research
• NN
  NIHR Newcastle Biomedical Research Centre
• NI
  National Institute of Neurological Disorders and Stroke
• NI
  National Institute for Dementia Research